On February 9, 2023 Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, reported its participation at three upcoming investor conferences (Press release, Nkarta, FEB 9, 2023, View Source [SID1234627000]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
SVB Securities Global Biopharma Conference
February 14, 2023
3:40 p.m. ET – fireside chat
H.C. Wainwright Cell Therapy Virtual Conference
February 28, 2023
Time tbd – fireside chat
Cowen 43RD Annual Health Care Conference
March 8, 2023
2:10 p.m. ET – industry panel discussion
A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.